Overview

D-cycloserine Augmented CBT for Panic Disorder

Status:
Terminated

Trial end date:
2018-04-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether d-cycloserine augments the clinical effects of exposure-based cognitive-behaviour therapy for panic disorder.

Phase:

Phase 3

Details

Lead Sponsor:

University of Oxford

Collaborator:

Medical Research Council

Treatments:

Cycloserine